Literature DB >> 9668072

Different regions of Rho determine Rho-selective binding of different classes of Rho target molecules.

K Fujisawa1, P Madaule, T Ishizaki, G Watanabe, H Bito, Y Saito, A Hall, S Narumiya.   

Abstract

Based on their Rho binding motifs several Rho target molecules can be classified into three groups; class I includes the protein kinase PKN, rhophilin, and rhotekin, class II includes the protein kinases, Rho-associated coiled-coil containing protein kinases, ROCK-I and ROCK-II, and class III includes citron. Taking advantage of the selectivity in recognition by these targets between Rho and Rac, we examined the regions in Rho required for selective binding of each class of Rho target molecules. Yeast two-hybrid assays were performed using Rho/Rac chimeras and either rhophilin, ROCK-I, or citron. This study showed the existence of at least two distinct regions in Rho (amino acids 23-40 and 75-92) that are critical for the selective binding of these targets. The former was required for binding to citron, whereas the latter was necessary for binding to rhophilin. On the other hand, either region showed affinity to ROCK-I. This was further confirmed by ligand overlay assay using both recombinant ROCK-I and ROCK-II proteins. Consistently, Rho/Rac chimeras containing either region can induce stress fibers in transfected HeLa cells, and this induction is suppressed by treatment with Y-27632, a specific inhibitor of ROCK kinases. These results suggest that the selective binding of different classes of Rho targets to Rho is determined by interaction between distinct Rho-binding motifs of the targets and different regions of Rho.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9668072     DOI: 10.1074/jbc.273.30.18943

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  The insert region of Rac1 is essential for membrane ruffling but not cellular transformation.

Authors:  A E Karnoub; C J Der; S L Campbell
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation.

Authors:  M K Pastey; J E Crowe; B S Graham
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  The insert region of RhoA is essential for Rho kinase activation and cellular transformation.

Authors:  H Zong; K Kaibuchi; L A Quilliam
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

4.  Cytotoxic necrotizing factor from Escherichia coli induces RhoA-dependent expression of the cyclooxygenase-2 Gene.

Authors:  W Thomas; Z K Ascott; D Harmey; L W Slice; E Rozengurt; A J Lax
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

5.  Physical and functional interactions of Galphaq with Rho and its exchange factors.

Authors:  S A Sagi; T M Seasholtz; M Kobiashvili; B A Wilson; D Toksoz; J H Brown
Journal:  J Biol Chem       Date:  2001-02-06       Impact factor: 5.157

Review 6.  Molecular parameters of head and neck cancer metastasis.

Authors:  Sanjay L Bhave; Theodoras N Teknos; Quintin Pan
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

7.  RhoE binds to ROCK I and inhibits downstream signaling.

Authors:  Kirsi Riento; Rosa M Guasch; Ritu Garg; Boquan Jin; Anne J Ridley
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

8.  Involvement of Rho family GTPases in p19Arf- and p53-mediated proliferation of primary mouse embryonic fibroblasts.

Authors:  Fukun Guo; Yi Zheng
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

Review 9.  Dynamics of the Rho-family small GTPases in actin regulation and motility.

Authors:  Désirée Spiering; Louis Hodgson
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

10.  RhoA inactivation prevents photoreceptor axon retraction in an in vitro model of acute retinal detachment.

Authors:  Aurora Maria Fontainhas; Ellen Townes-Anderson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.